Colgate-Palmolive (NYSE:CL) Shares Sold by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System decreased its position in Colgate-Palmolive (NYSE:CLFree Report) by 4.6% during the 4th quarter, Holdings Channel reports. The fund owned 43,900 shares of the company’s stock after selling 2,100 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Colgate-Palmolive were worth $3,991,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Portfolio Design Labs LLC acquired a new stake in shares of Colgate-Palmolive during the 4th quarter worth about $228,000. Sapient Capital LLC raised its holdings in Colgate-Palmolive by 1.6% during the fourth quarter. Sapient Capital LLC now owns 9,990 shares of the company’s stock worth $908,000 after purchasing an additional 157 shares in the last quarter. Arlington Trust Co LLC raised its holdings in Colgate-Palmolive by 29.5% during the fourth quarter. Arlington Trust Co LLC now owns 3,814 shares of the company’s stock worth $347,000 after purchasing an additional 868 shares in the last quarter. Equitable Trust Co. acquired a new stake in Colgate-Palmolive during the fourth quarter worth approximately $212,000. Finally, Soltis Investment Advisors LLC raised its holdings in Colgate-Palmolive by 374.4% during the fourth quarter. Soltis Investment Advisors LLC now owns 10,745 shares of the company’s stock worth $977,000 after purchasing an additional 8,480 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $86.75 on Thursday. Colgate-Palmolive has a 52 week low of $82.76 and a 52 week high of $109.30. The company has a 50-day moving average price of $90.00 and a 200 day moving average price of $96.61. The company has a market cap of $70.88 billion, a P/E ratio of 24.64, a PEG ratio of 4.12 and a beta of 0.44. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the business posted $0.87 earnings per share. Research analysts predict that Colgate-Palmolive will post 3.73 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.31%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 56.82%.

Analysts Set New Price Targets

CL has been the topic of several research analyst reports. Raymond James reiterated an “outperform” rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Royal Bank of Canada reiterated a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Morgan Stanley cut their price target on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. TD Cowen cut their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Finally, UBS Group cut their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $101.16.

View Our Latest Stock Analysis on Colgate-Palmolive

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.